1.21

0.83% 0.01

After Hours: 1.20 -0.01 -0.83%

Lucid Diagnostics Inc (LUCD)

Overview News Price History Financials Discussions Forecast

Lucid Diagnostics Inc stock is traded at $1.21, with a volume of 499.67K. It is up +0.83% in the last 24 hours and up +19.80% over the past month. Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Previous Close:

$1.20

Open:

$1.2

24h Volume:

499.67K

Relative Volume:

0.43

Market Cap:

$166.05M

Revenue:

$4.35M

Net Income/Loss:

$-45.53M

P/E Ratio:

-1.1204

EPS:

-1.08

Net Cash Flow:

$-44.79M

1W Performance:

-5.47%

1M Performance:

+19.80%

6M Performance:

-3.20%

1Y Performance:

+24.87%

1-Day Range:

$1.19

$1.22

1-Week Range:

$1.19

$1.29

52-Week Range:

$0.7501

$1.80

Lucid Diagnostics Inc Stock (LUCD) Company Profile

Name

Lucid Diagnostics Inc

Sector

Healthcare (1135)

Industry

Medical Devices (144)

Phone

212 949 4319

Address

360 MADISON AVENUE, NEW YORK

Employee

Twitter

Next Earnings Date

2025-03-24

Latest SEC Filings

LUCD's Discussions on Twitter

Compare LUCD with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LUCD Lucid Diagnostics Inc	1.21	122.27M	4.35M	-45.53M	-44.79M	-1.08
ABT Abbott Laboratories	123.62	216.79B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	100.72	149.02B	19.35B	2.78B	3.49B	1.8696
SYK Stryker Corp	356.24	141.06B	24.38B	2.94B	4.02B	7.6145
MDT Medtronic Plc	90.70	116.68B	34.20B	4.69B	5.30B	3.6218
EW Edwards Lifesciences Corp	82.45	49.01B	5.88B	1.34B	577.90M	2.3455

Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-27-21	Initiated	Ascendiant Capital Markets	Buy
Nov-08-21	Initiated	BTIG Research	Buy
Nov-08-21	Initiated	Cantor Fitzgerald	Overweight
Nov-08-21	Initiated	Needham	Buy

Lucid Diagnostics Inc Stock (LUCD) Latest News

Nov 02, 2025

Is Lucid Diagnostics Inc. meeting your algorithmic filter criteriaQuarterly Portfolio Summary & Daily Chart Pattern Signals - newser.com

Nov 02, 2025

Live market analysis of Lucid Diagnostics Inc.Stock Surge & AI Forecasted Entry/Exit Points - newser.com

Nov 02, 2025

Is Lucid Diagnostics Inc. stock ready for a breakoutJobs Report & Expert Curated Trade Setups - newser.com

Nov 02, 2025

Is Lucid Diagnostics Inc. stock supported by innovation pipelineJuly 2025 WrapUp & Weekly Watchlist of Top Performers - newser.com

Nov 02, 2025

Nov 01, 2025

Measuring Lucid Diagnostics Inc.’s beta against major indicesJuly 2025 Outlook & AI Optimized Trade Strategies - newser.com

Nov 01, 2025

Is Lucid Diagnostics Inc. stock oversold or undervalued2025 Sector Review & Risk Adjusted Buy/Sell Alerts - newser.com

Nov 01, 2025

Will Lucid Diagnostics Inc. stock maintain momentum in 2025Earnings Growth Report & Risk Adjusted Buy/Sell Alerts - newser.com

Nov 01, 2025

Oct 31, 2025

Combining machine learning predictions for Lucid Diagnostics Inc.Weekly Trade Analysis & Verified Trade Idea Suggestions - newser.com

Oct 31, 2025

Can Lucid Diagnostics Inc. stock sustain revenue growthWeekly Risk Report & Verified Entry Point Signals - newser.com

Oct 31, 2025

How Lucid Diagnostics Inc. stock reacts to oil pricesJuly 2025 Patterns & Weekly High Momentum Picks - newser.com

Oct 31, 2025

Will Lucid Diagnostics Inc. stock continue dividend increasesRate Cut & Fast Exit and Entry Trade Guides - newser.com

Oct 31, 2025

Why retail investors favor Lucid Diagnostics Inc. stockBuy Signal & Low Drawdown Trading Strategies - newser.com

Oct 31, 2025

Oct 30, 2025